Stock Track | Integer Soars 6.96% in Pre-market on Strong Q4 Earnings Beat and Upbeat 2026 Guidance

Stock Track
Feb 19

Integer Holdings Corporation's stock surged 6.96% in pre-market trading following the release of its fourth-quarter and full-year 2025 financial results, which exceeded analyst expectations across key metrics.

The medical device maker reported Q4 sales of $472 million, beating the consensus estimate of $462.7 million. Adjusted earnings per share for the quarter came in at $1.76, surpassing the estimated $1.70. The strong performance was primarily driven by an 11% sales growth in the Cardio & Vascular segment, fueled by acquisitions and robust demand in Neurovascular.

Furthermore, the company provided optimistic guidance for 2026, expecting sales in the range of $1.83 billion to $1.88 billion, compared to the FactSet estimate of $1.84 billion. Adjusted EPS is projected to be between $6.29 and $6.78, versus the consensus estimate of $6.30. Integer also announced its intention to commence an accelerated share repurchase program of $50 million and expects to return to 200 basis points above-market organic sales growth in 2027.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10